Skip to content Skip to footer

GBM AGILE New Clinical Trial Sites Being Established

In the first half of 2020, the revolutionary global clinical trial for brain cancer patients, GBM AGILE, continues to make impressive progress and achieve milestones. AFCR supported its conception in 2013 to expeditiously develop new effective treatments for GBM brain cancer patients…

GBM AGILE: A Patient’s Perspective

Speech by AFCR Founder and CEO Dr. Ba Sujuan at the Beijing GBM AGILE Press Conference    (21 January, 2016) Brain cancer patients are remarkably courageous. So are their caregivers, families and friends. The financial and emotional burden to GBM patients and indeed all…

GBM – the Most Deadliest Brain Cancer Needs Your Help!

What is Glioblastoma (GBM)? Glioblastoma, referred to simply as GBM, is the deadliest type of brain cancer. GBM is widely regarded as incurable and universally fatal, killing 95% of patients within five years of diagnosis. GBM survival rates have not improved in…

Global Collaborative Platforms

Global Collaborative Platforms HomeGlobal Collaborative Platforms Women Venture Competition July 29, 2024 Global Collaborative Platforms…

Innovative Therapies and Treatments

Innovative Therapies and Treatments HomeInnovative Therapies and Treatments Building Safer, More Effective CAR-T Cell Therapies…

About the BRACE Award

About the BRACE Award HomeAbout the BRACE Award Program Overview The Asian Fund for Cancer Research (AFCR) is proud to present the Bridging Research from Academia to Cancer Entrepreneurship (BRACE) Award Venture Competition. The BRACE Award aims to provide vital support to early-stage biotechs,…

Research Program

Research Program HomeResearch Program Funded Cancer Research Breakthroughs in cancer research require connections, collaboration and dedicated efforts from scientists and clinicians. AFCR is dedicated to sponsoring and supporting innovative research projects that unlock new information about how cancer forms and spreads, and, most…

Promising Cancer Research Programs Need Your Help!

I am writing today to ask for your 2022 Annual Fund renewal gift to the Asian Fund for Cancer Research, and your decision is absolutely crucial! Currently, talented scientists are waiting for funding to pursue potentially life-saving research projects . Generous friends…